Influence of Selenium on Prostate Cancer Related Biomarkers

Completed · Not applicable · Has a placebo group

Conditions studied: Effect of Selenium on Oxidative Stress in Healthy Men

In brief

Penn State Milton S. Hershey Medical Center researchers are trying to compare the effects of two different forms of selenium (selenium yeast and selenomethionine) on blood selenium levels and biomarkers of oxidative stress as primary endpoints. One in six men are at risk of getting prostate cancer in their lifetime. Participants will be asked to take over-the-counter selenium yeast supplements and selenomethionine or a placebo for nine out of twelve months.

Key facts

Study ID

NCT01112449

Run by

Milton S. Hershey Medical Center

People needed

130

Starts

2008-05-01

Expected to finish

2014-05-01

Last updated by the study team

2015-07-10

Who can join

Age: 20 and older, up to 79. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• No history or evidence of diabetes
• Male between the ages of 20-79
• PSA levels ≤ 4.0 ng/mL
• Not taking >50 µg/day selenium as a dietary supplement including multi- vitamins
• Non-smoker
• No concurrently participating or have participated in any other clinical trial within at least 30 days of registration
• Health male

You may not qualify if…

• Evidence of prostate cancer
• Evidence of liver or kidney disease

Where it is running

• Penn State Milton Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.